Printer Friendly

SYNERGEN FILES REGISTRATION STATEMENT FOR 3,000,000 SHARES OF COMMON STOCK

               SYNERGEN FILES REGISTRATION STATEMENT
               FOR 3,000,000 SHARES OF COMMON STOCK
    BOULDER, Colo., Nov. 7 /PRNewswire/ -- Synergen Inc. (NASDAQ: SYGN) announced today that it has filed a registration statement with the Securities and Exchange Commission for the proposed sale by the company of 3,000,000 shares of its Common Stock.  Alex. Brown & Sons Inc. and Robertson, Stephens & Co. are co-managing the offering.
    The company expects to use the net proceeds from the proposed offering for working capital and other general corporate purposes.
    Synergen is a biopharmaceutical company engaged in the discovery, development and manufacture of protein-based pharmaceuticals.
    -0-                        11/7/91
    /NOTE: A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective.  These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.  This release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
    /CONTACT:  Debra Catz Bannister of Synergen, 303-938-6242/
    (SYGN) CO:  Synergen Inc. ST:  Colorado IN:  MTC SU: SG -- DV004 -- 2237 11/07/91 12:46 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 7, 1991
Words:225
Previous Article:PDLA ANNOUNCES RESIGNATION OF DIRECTOR AND ELECTION OF NEW CHAIRMAN OF THE BOARD
Next Article:PUBLIC SERVICE COMPANY REPORTS FISCAL 1991 EARNINGS
Topics:


Related Articles
SYNERGEN REVISES PARTNERSHIP OFFER
NOVA PHARMACEUTICAL FILES REGISTRATION STATEMENT FOR COMMON STOCK OFFERING
WATSON PHARMACEUTICALS ANNOUNCES FILING OF REGISTRATION STATEMENT FOR INITIAL PUBLIC OFFERING
NETFRAME SYSTEMS FILES FOR INITIAL PUBLIC OFFERING OF 3,000,000 SHARES OF COMMON STOCK
SYNERGEN COMPLETES BUYOUT OF R&D PARTNERSHIP
WATSON PHARMACEUTICALS ANNOUNCES INTENT TO FILE REGISTRATION STATEMENT FOR OFFERING OF COMMON STOCK
LA JOLLA PHARMACEUTICAL COMPANY FILES REGISTRATION
AUTOIMMUNE INC. FILES REGISTRATION STATEMENT WITH SEC FOR PUBLIC OFFERING
VERTEX PHARMACEUTICALS FILES REGISTRATION STATEMENT WITH SEC TO SELL 3,000,000 SHARES OF COMMON STOCK
Celgene Corporation Increases Size of Proposed Common Stock Offering.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters